1. Home
  2. PTHL vs PBHC Comparison

PTHL vs PBHC Comparison

Compare PTHL & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • PBHC
  • Stock Information
  • Founded
  • PTHL 1998
  • PBHC 1859
  • Country
  • PTHL China
  • PBHC United States
  • Employees
  • PTHL N/A
  • PBHC N/A
  • Industry
  • PTHL
  • PBHC Major Banks
  • Sector
  • PTHL
  • PBHC Finance
  • Exchange
  • PTHL Nasdaq
  • PBHC Nasdaq
  • Market Cap
  • PTHL 85.4M
  • PBHC 93.1M
  • IPO Year
  • PTHL 2024
  • PBHC N/A
  • Fundamental
  • Price
  • PTHL $0.63
  • PBHC $15.03
  • Analyst Decision
  • PTHL
  • PBHC
  • Analyst Count
  • PTHL 0
  • PBHC 0
  • Target Price
  • PTHL N/A
  • PBHC N/A
  • AVG Volume (30 Days)
  • PTHL 3.5M
  • PBHC 3.0K
  • Earning Date
  • PTHL 01-01-0001
  • PBHC 07-30-2025
  • Dividend Yield
  • PTHL N/A
  • PBHC 2.66%
  • EPS Growth
  • PTHL N/A
  • PBHC N/A
  • EPS
  • PTHL N/A
  • PBHC 0.24
  • Revenue
  • PTHL $448,196.00
  • PBHC $39,015,000.00
  • Revenue This Year
  • PTHL N/A
  • PBHC N/A
  • Revenue Next Year
  • PTHL N/A
  • PBHC N/A
  • P/E Ratio
  • PTHL N/A
  • PBHC $63.45
  • Revenue Growth
  • PTHL N/A
  • PBHC N/A
  • 52 Week Low
  • PTHL $0.60
  • PBHC $13.71
  • 52 Week High
  • PTHL $32.00
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • PBHC 56.42
  • Support Level
  • PTHL N/A
  • PBHC $14.29
  • Resistance Level
  • PTHL N/A
  • PBHC $14.98
  • Average True Range (ATR)
  • PTHL 0.00
  • PBHC 0.25
  • MACD
  • PTHL 0.00
  • PBHC 0.03
  • Stochastic Oscillator
  • PTHL 0.00
  • PBHC 83.78

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: